US

AccuStart Long Range SuperMix

Superior sensitivity and multiplexing for DNA amplification of long targets
Features & Benefits
  • Amplify +24 kb gDNA and +40 kb lambda DNA
  • 4x concentration enables superior sensitivity with low inputs (100 pg)
  • Multiplex up to 6 targets with each target up to 6 kb in length
  • Stabilized, single-tube SuperMix minimizes pipetting errors and hands-on-time
  • Reliable lot-to-lot reproducibility ensures consistent results
  • Amplification through uracils and primers containing inosines/uracils

 

AccuStart Long Range SuperMix is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of a disease.

Product
Kit Size
Part Number
Price
Quantity
 
Product
Kit Size
Order Info
Price
Quantity
AccuStart Long Range SuperMix
Request Sample
Kit Size:
Part Number:
Price:
Quantity:
Kit Size:  25 rxns
Part Number:  95199-025
Price:  $93.00
Add to Cart
Kit Size:  100 rxns
Part Number:  95199-100
Price:  $310.00
Add to Cart
To place your order through VWR, click here

Description

The AccuStart Long Range SuperMix is a 4x, ready-to-use solution that contains all the components for long range target amplifications, including a blend of two hot-start thermostable DNA polymerases (one with strong proof-reading activity) and an optimized buffer to ensure high efficiency, sensitivity and specificity.

The SuperMix enables routine and easy amplification of up to 24kb target from gDNA with high accuracy (> 10-fold better fidelity than Taq) and accommodates targets with broad GC-content (no separate GC buffer needed). This product is also capable of amplifying multiple targets simultaneously and is suitable for end point PCR, template prep for sanger sequencing, NGS, cloning and HLA typing.

 

Details

Details

Contents
  • 4x ready-to-use solution
Performance Data

Performance Data

Superior sensitivity and yield
Long-range amplification with high yields
Multiplexing: consistent amplification of multiple targets
Reproducible results thanks to lot-to-lot consistency
Resource Panel
Customer Testimonials

Customer Testimonials

AccuStart Long Range SuperMix

"We got our 7 Kb band! and with good intensity, so lots amplicons for downstream applications."

Project Coordinator | Sick Kids Hospital
AccuStart Long Range SuperMix

"Easy to set up with all reagents required for long range PCR in one place."

R&D Scientist | ARUP
AccuStart Long Range SuperMix

"Overall it helped me improve my PCR with the intensity of the product, and easy one tube of mix to everything. Very satisfied with the result giving so far."

Lab Manager | University of Oklahoma Health Sciences Center
AccuStart Long Range SuperMix

"The AccuStart Long Range SuperMix produced a clean long-range product (10 kbp) on our first try! We are excited to have a reliable and easy-to-use polymerase to produce DNA for single-molecule studies."

Danielle M. | Professor, Stanford University

Details

Contents
  • 4x ready-to-use solution

Performance Data

Superior sensitivity and yield
Long-range amplification with high yields
Multiplexing: consistent amplification of multiple targets
Reproducible results thanks to lot-to-lot consistency

Resources

Flyers

Product Manuals

CofA (PSFs)
Click here to see all CofA (PSFs)

SDSs

Publications

FXN gene methylation determines carrier status in Friedreich ataxia
Christina Lam - 2023
Abstract
Background Friedreich ataxia (FRDA) is typically caused by homozygosity for an expanded GAA triplet-repeat (GAA-TRE) in intron 1 of the FXN gene. Some patients are compound heterozygous for the GAA-TRE and another FXN pathogenic variant. Detection of the GAA-TRE in the heterozygous state, occasionally technically challenging, is essential for diagnosing compound heterozygotes and asymptomatic carriers. Objective We explored if the FRDA differentially methylated region (FRDA-DMR) in intron 1, which is hypermethylated in cis with the GAA-TRE, effectively detects heterozygous GAA-TRE. Methods FXN DNA methylation was assayed by targeted bisulfite deep sequencing using the Illumina platform. Results FRDA-DMR methylation effectively identified a cohort of known heterozygous carriers of the GAA-TRE. In an individual with clinical features of FRDA, commercial testing showed a paternally inherited pathogenic FXN initiation codon variant but no GAA-TRE. Methylation in the FRDA-DMR effectively identified the proband, his mother and various maternal relatives as heterozygous carriers of the GAA-TRE, thus confirming the diagnosis of FRDA. Conclusion FXN DNA methylation reliably detects the GAA-TRE in the heterozygous state and offers a robust alternative strategy to diagnose FRDA due to compound heterozygosity and to identify asymptomatic heterozygous carriers of the GAA-TRE.
Comprehensive variant calling from whole-genome sequencing identifies a complex inversion that disrupts ZFPM2 in familial congenital diaphragmatic hernia
Thomas J. Nicholas - 2022
Abstract
Background: Genetic disorders contribute to significant morbidity and mortality in critically ill newborns. Despite advances in genome sequencing technologies, a majority of neonatal cases remain unsolved. Complex structural variants (SVs) often elude conventional genome sequencing variant calling pipelines and will explain a portion of these unsolved cases. Methods: As part of the Utah NeoSeq project, we used a research-based, rapid whole-genome sequencing (WGS) protocol to investigate the genomic etiology for a newborn with a left-sided congenital diaphragmatic hernia (CDH) and cardiac malformations, whose mother also had a history of CDH and atrial septal defect. Results: Using both a novel, alignment-free and traditional alignment-based variant callers, we identified a maternally inherited complex SV on chromosome 8, consisting of an inversion flanked by deletions. This complex inversion, further confirmed using orthogonal molecular techniques, disrupts the ZFPM2 gene, which is associated with both CDH and various congenital heart defects. Conclusions: Our results demonstrate that complex structural events, which often are unidentifiable or not reported by clinically validated testing procedures, can be discovered and accurately characterized with conventional, short-read sequencing and underscore the utility of WGS as a first-line diagnostic tool.
DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
Layne N. Rodden - 2022
Abstract
Epigenetic silencing in Friedreich ataxia (FRDA), induced by an expanded GAA triplet-repeat in intron 1 of the FXN gene, results in deficiency of the mitochondrial protein, frataxin. A lesser known extramitochondrial isoform of frataxin detected in erythrocytes, frataxin-E, is encoded via an alternate transcript (FXN-E) originating in intron 1 that lacks a mitochondrial targeting sequence. We show that FXN-E is deficient in FRDA, including in patient-derived cell lines, iPS-derived proprioceptive neurons, and tissues from a humanized mouse model. In a series of FRDA patients, deficiency of frataxin-E protein correlated with the length of the expanded GAA triplet-repeat, and with repeat-induced DNA hypermethylation that occurs in close proximity to the intronic origin of FXN-E. CRISPR-induced epimodification to mimic DNA hypermethylation seen in FRDA reproduced FXN-E transcriptional deficiency. Deficiency of frataxin E is a consequence of FRDA-specific epigenetic silencing, and therapeutic strategies may need to address this deficiency.
Comprehensive variant calling from whole-genome sequencing identifies a complex inversion that disrupts ZFPM2 in familial congenital diaphragmatic hernia
Thomas J. Nicholas - 2022
Abstract
Background: Genetic disorders contribute to significant morbidity and mortality in critically ill newborns. Despite advances in genome sequencing technologies, a majority of neonatal cases remain unsolved. Complex structural variants (SVs) often elude conventional genome sequencing variant calling pipelines and will explain a portion of these unsolved cases. Methods: As part of the Utah NeoSeq project, we used a research-based, rapid whole-genome sequencing (WGS) protocol to investigate the genomic etiology for a newborn with a left-sided congenital diaphragmatic hernia (CDH) and cardiac malformations, whose mother also had a history of CDH and atrial septal defect. Results: Using both a novel, alignment-free and traditional alignment-based variant callers, we identified a maternally inherited complex SV on chromosome 8, consisting of an inversion flanked by deletions. This complex inversion, further confirmed using orthogonal molecular techniques, disrupts the ZFPM2 gene, which is associated with both CDH and various congenital heart defects. Conclusions: Our results demonstrate that complex structural events, which often are unidentifiable or not reported by clinically validated testing procedures, can be discovered and accurately characterized with conventional, short-read sequencing and underscore the utility of WGS as a first-line diagnostic tool.
Genomic Characterization of the Fruity Aroma Gene, FaFAD1, Reveals a Gene Dosage Effect on γ-Decalactone Production in Strawberry (Fragaria × ananassa)
Youngjae Oh - 2021
Abstract
Strawberries produce numerous volatile compounds that contribute to the unique flavors of fruits. Among the many volatiles, γ-decalactone (γ-D) has the greatest contribution to the characteristic fruity aroma in strawberry fruit. The presence or absence of γ-D is controlled by a single locus, FaFAD1. However, this locus has not yet been systematically characterized in the octoploid strawberry genome. It has also been reported that the volatile content greatly varies among the strawberry varieties possessing FaFAD1, suggesting that another genetic factor could be responsible for the different levels of γ-D in fruit. In this study, we explored the genomic structure of FaFAD1 and determined the allele dosage of FaFAD1 that regulates variations of γ-D production in cultivated octoploid strawberry. The genome-wide association studies confirmed the major locus FaFAD1 that regulates the γ-D production in cultivated strawberry. With the hybrid capture-based next-generation sequencing analysis, a major presence–absence variation of FaFAD1 was discovered among γ-D producers and non-producers. To explore the genomic structure of FaFAD1 in the octoploid strawberry, three bacterial artificial chromosome (BAC) libraries were developed. A deletion of 8,262 bp was consistently found in the FaFAD1 region of γ-D non-producing varieties. With the newly developed InDel-based codominant marker genotyping, along with γ-D metabolite profiling data, we revealed the impact of gene dosage effect for the production of γ-D in the octoploid strawberry varieties. Altogether, this study provides systematic information of the prominent role of FaFAD1 presence and absence polymorphism in producing γ-D and proposes that both alleles of FaFAD1 are required to produce the highest content of fruity aroma in strawberry fruit.

Customer Testimonials

AccuStart Long Range SuperMix

"We got our 7 Kb band! and with good intensity, so lots amplicons for downstream applications."

Project Coordinator | Sick Kids Hospital
AccuStart Long Range SuperMix

"Easy to set up with all reagents required for long range PCR in one place."

R&D Scientist | ARUP
AccuStart Long Range SuperMix

"Overall it helped me improve my PCR with the intensity of the product, and easy one tube of mix to everything. Very satisfied with the result giving so far."

Lab Manager | University of Oklahoma Health Sciences Center
AccuStart Long Range SuperMix

"The AccuStart Long Range SuperMix produced a clean long-range product (10 kbp) on our first try! We are excited to have a reliable and easy-to-use polymerase to produce DNA for single-molecule studies."

Danielle M. | Professor, Stanford University

Welcome to the Quantabio webshop!

Please complete the new user account registration form

Once your account is setup, you'll be able to purchase any of the products on our site at any time with next day delivery for in stock products.

Product Finder

Select Your Assay

Starting Template

Back

Assay Format

Back

Detection Chemistry

Back

Multiplexing (more than 3 targets)

Back

Is gene-specific priming (GSP) required?

Back

What current Reverse Transcriptase or cDNA kit are you using?

Back

Select the group which contains your real-time PCR cycler

  • Applied Biosystems 7500
  • Applied Biosystems 7500 Fast
  • Stratagene Mx3000P®
  • Stratagene Mx3005P™
  • Stratagene Mx4000™
  • Applied Biosystems ViiA 7
  • Applied Biosystems QuantStudio™
  • Agilent AriaMx
  • Douglas Scientific IntelliQube®
  • Applied Biosystems 5700
  • Applied Biosystems 7000
  • Applied Biosystems 7300
  • Applied Biosystems 7700
  • Applied Biosystems 7900
  • Applied Biosystems 7900HT
  • Applied Biosystems 7900 HT Fast
  • Applied Biosystems StepOne™
  • Applied Biosystems StepOnePlus™
  • Quantabio Q
  • BioRad CFX
  • Roche LightCycler 480
  • QIAGEN Rotor-Gene Q
  • Azure Cielo 6
  • Azure Cielo 3
  • Other
  • BioRad iCycler iQ™
  • BioRad MyiQ™
  • BioRad iQ™5
Back

Choose your application from the categories below

Back

Products

Back Next
I give Quantabio or an authorized Quantabio distributor permission to contact me for product updates and news.
* Required information
Back